As shown in Fig. 1c, despite the variability in GBM, we found that Bcl-xL and Mcl-1 represent the most abundantly expressed anti-apoptotic factors in all tested GSC-ECLs while Bcl-w, followed by Bcl-2, exhibit the lowest expression levels. This evidence concerns the gene BCL2L2 and glioblastoma.